UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.031

Sortiert nach

Clinical pharmacology of the SingleTablet Regimen (STR) Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF)

Le infezioni in medicina, 2023, Vol.31 (3), p.283-289

Di Perri, Giovanni

2023

Volltextzugriff (PDF)

Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy

Emerging infectious diseases, 2021-01, Vol.27 (1), p.303-305

2021

Volltextzugriff (PDF)

The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics

Journal of antimicrobial chemotherapy, 2020-09, Vol.75 (9), p.2381-2383

2020

Volltextzugriff (PDF)

A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?

Current drug metabolism, 2014-01, Vol.15 (6), p.581

2014

Volltextzugriff (PDF)

Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot Study

The Journal of infectious diseases, 2020-06, Vol.222 (2), p.263-272

2020

Volltextzugriff (PDF)

Antiviral Therapy in Patients With Hepatitis B Virus Treated for Tuberculosis: A Forgotten Issue

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1583-1584

2020

Volltextzugriff (PDF)

2019 novel coronavirus (2019-nCoV) outbreak: A new challenge

Journal of global antimicrobial resistance., 2020-06, Vol.21, p.22-27

2020

Volltextzugriff (PDF)

Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.581-589

2014

Volltextzugriff (PDF)

Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers

The Journal of steroid biochemistry and molecular biology, 2021-06, Vol.210, p.105854-105854, Article 105854

2021

Volltextzugriff (PDF)

The “scar” of a pandemic: Cumulative incidence of COVID‐19 during the first trimester of pregnancy

Journal of medical virology, 2021-01, Vol.93 (1), p.537-540

2021

Volltextzugriff (PDF)

SIMpLE: A Mobile Cloud-Based System for Health Monitoring of People with ALS

Sensors (Basel, Switzerland), 2021-10, Vol.21 (21), p.7239

2021

Volltextzugriff (PDF)

The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study

Antimicrobial agents and chemotherapy, 2022-06, Vol.66 (6), p.e0013622-e0013622

2022

Volltextzugriff (PDF)

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases

The Lancet infectious diseases, 2021-07, Vol.21 (7), p.914-915

2021

Volltextzugriff (PDF)

Pharmacogenetic of voriconazole antifungal agent in pediatric patients

Pharmacogenomics, 2018-07, Vol.19 (11), p.913-925

2018

Volltextzugriff (PDF)

Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort

PloS one, 2019-10, Vol.14 (10), p.e0222225

2019

Volltextzugriff (PDF)

Obstetric and neonatal outcomes after SARS‐CoV‐2 infection in the first trimester of pregnancy: A prospective comparative study

The journal of obstetrics and gynaecology research, 2022-02, Vol.48 (2), p.393-401

2022

Volltextzugriff (PDF)

Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective study

Archives of virology, 2021-04, Vol.166 (4), p.1125-1131

2021

Volltextzugriff (PDF)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia

Lung, 2022-10, Vol.200 (5), p.573-577

2022

Volltextzugriff (PDF)

Patterns of Cerebrospinal Fluid Alzheimer's Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition

Viruses, 2022-04, Vol.14 (4), p.753

2022

Volltextzugriff (PDF)

Good times, bad times: A diary of a physician in the COVID-19 era

European journal of internal medicine, 2020-07, Vol.77, p.132-133

2020

Volltextzugriff (PDF)

Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease

Journal of antimicrobial chemotherapy, 2020-07, Vol.75 (7), p.1772-1777

2020

Volltextzugriff (PDF)

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study

Journal of clinical virology plus, 2024-02, Vol.4 (1), p.100174, Article 100174

2024

Volltextzugriff (PDF)

Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients

The pharmacogenomics journal, 2020-04, Vol.20 (2), p.202-212

2020

Volltextzugriff (PDF)

Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-01, Vol.26 (1), p.18-22

2020

Volltextzugriff (PDF)

Association of a Single-Nucleotide Polymorphism in the Pregnane X Receptor (PXR 63396C→T) with Reduced Concentrations of Unboosted Atazanavir

Clinical infectious diseases, 2008-11, Vol.47 (9), p.1222-1225

2008

Volltextzugriff (PDF)

1 – 25 von 1.031

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(962)
Mit Volltextzugriff
(937)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Clinical pharmacology of the SingleTablet Regimen (STR) Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF)

Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy

The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics

A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?

Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot Study

Antiviral Therapy in Patients With Hepatitis B Virus Treated for Tuberculosis: A Forgotten Issue

2019 novel coronavirus (2019-nCoV) outbreak: A new challenge

Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers

The “scar” of a pandemic: Cumulative incidence of COVID‐19 during the first trimester of pregnancy

SIMpLE: A Mobile Cloud-Based System for Health Monitoring of People with ALS

The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases

Pharmacogenetic of voriconazole antifungal agent in pediatric patients

Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort

Obstetric and neonatal outcomes after SARS‐CoV‐2 infection in the first trimester of pregnancy: A prospective comparative study

Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective study

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia

Patterns of Cerebrospinal Fluid Alzheimer's Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition

Good times, bad times: A diary of a physician in the COVID-19 era

Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study

Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients

Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders

Association of a Single-Nucleotide Polymorphism in the Pregnane X Receptor (PXR 63396C→T) with Reduced Concentrations of Unboosted Atazanavir

Suchergebnisse filtern